Friday, January 4, 2013

• HALOZYME THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct FinancEDGAR Online (Fri, Jan 4)
• The Story Behind Little Halozyme’s Seemingly Exciting Hookup With PfizerYCharts (Fri, Jan 4)
• Insider Buying Trends: Are These Cash Rich Companies Ready To Rally?at Seeking Alpha (Fri, Jan 4)

Thursday, January 3, 2013

• Halozyme Therapeutics's Key Deal With Pfizer Is Significantat Seeking Alpha (Thu, Jan 3)

Wednesday, January 2, 2013

• Some Stocks to Cheer You Up!at Motley Fool (Wed, Jan 2)

Saturday, December 29, 2012

• Pfizer’s Backing Spurs Halozyme's Growthat Motley Fool (Sat, Dec 29)

Wednesday, December 26, 2012

• Pfizer Signs a Couple of DealsZacks (Wed, Dec 26)

Monday, December 24, 2012

• Whoa! A Year-End Rally for These 3 Stocksat Motley Fool (Mon, Dec 24)
• 5 Biotech Winners From Last Week With High Short Ratiosat Seeking Alpha (Mon, Dec 24)

Sunday, December 23, 2012

• 3 Humongous Health-Care Stocks This Weekat Motley Fool (Sun, Dec 23)

Saturday, December 22, 2012

• This Week in Biotechat Motley Fool (Sat, Dec 22)

Friday, December 21, 2012

• Why Halozyme Shares Soaredat Motley Fool (Fri, Dec 21)
• Halozyme Jumps Most in Six Years on Pfizer Partnershipat Bloomberg (Fri, Dec 21)
• Halozyme Therapeutics Set To Shine On Deal With Pfizerat Seeking Alpha (Fri, Dec 21)
• Halozyme Partners with Pfizer, Venaxiz Seeks CE Mark for APPY1: Healthcare Business Recapat Wall St. Cheat Sheet (Fri, Dec 21)
• Pfizer Licenses Halozyme's Enhanze Technologyat Motley Fool (Fri, Dec 21)
• Halozyme Surges on Pfizer Dealat Motley Fool (Fri, Dec 21)
• 2 Biotech Stocks Worth Going Long On In The Wake Of Recent Developmentsat Seeking Alpha (Fri, Dec 21)
• Panera and Other Big Movers on the Nasdaq on December 21, 2012at Investopedia (Fri, Dec 21)
• Healthcare Stocks, Including Thermo Fisher, Making Big Moves on December 21, 2012at Investopedia (Fri, Dec 21)
• Halozyme inks drug development deal with PfizerAP (Fri, Dec 21)

Wednesday, December 19, 2012

• ViroPharma, Halozyme announce initiation of Phase 2b dose to evaluate Cinryzeat theflyonthewall.com (Wed, Dec 19)

Wednesday, December 12, 2012

• 4 Promising Biotech Stocks To Consider Nowat Seeking Alpha (Wed, Dec 12)

Monday, December 10, 2012

• Halozyme Gains on $4 Million Payment: Los Angeles Moverat Bloomberg (Mon, Dec 10)
• U.S. Stocks Rise on China Amid American Budget Talksat Bloomberg (Mon, Dec 10)

Add HALO News to My Yahoo!